Grammidin for children, tablets 1.5 mg+1 mg 18 pcs

Tonsillitis, Pharyngitis, Angina, Inflammation in the mouth, Periodontitis, Sore throat, Stomatitis

Symptomatic treatment of infectious and inflammatory diseases of the mouth and throat, accompanied by pain in the throat and oral cavity:

Pharyngitis;

Tonsillitis;

Parodontitis;

Gingivitis;

Stomatitis.

Indications

Symptomatic treatment of infectious and inflammatory diseases of the mouth and throat, accompanied by pain in the throat and oral cavity:

– pharyngitis;

– tonsillitis;

– periodontitis;

– gingivitis;

– stomatitis.

Special instructions

Grammidin for children should not be taken if there are open wounds in the mouth, since cetylpyridinium chloride slows down wound healing.

Impact on the ability to drive vehicles and operate machinery

The drug does not affect the performance of potentially hazardous activities that require special attention and quick reactions (driving a car and other vehicles, working with moving mechanisms, working as a dispatcher and operator, etc.).

Active ingredient

Gramicidin C, Cetylpyridinium chloride

Composition

One tablet contains:
active substances:
gramicidin C dihydrochloride – 1.60 mg (in terms of gramicidin C – 1.50 mg);
cetylpyridinium chloride monohydrate – 1.05 mg (in terms of cetylpyridinium chloride – 1.00 mg);
excipients:
colloidal silicon dioxide -5.00 mg, talc -60.00 mg, citric acid monohydrate -36.00 mg, aspartame -12.00 mg, raspberry flavor -3.60 mg, sorbitol -1055.75 mg, magnesium stearate -25.00 mg.

Contraindications

— Hypersensitivity to the components of the drug;

– phenylketonuria (the drug contains aspartame);

– lactation period;

– children under 4 years of age.

Side Effects

Allergic reactions to the components of the drug, gastrointestinal disorders (nausea, diarrhea) are possible.

Interaction

Currently, there are no cases of clinically significant interactions with other drugs.

Overdose

Symptoms: taking the drug in doses higher than recommended may cause gastrointestinal disorders due to changes in the bacterial microflora: nausea, vomiting, diarrhea.

Treatment: you should stop taking the drug and consult a doctor.

Clinical pharmacology

A combined drug for the symptomatic treatment of infectious and inflammatory diseases of the throat and oral cavity. The drug contains the antimicrobial agent gramicidin C and the antiseptic agent cetylpyridinium chloride.

The mechanism of action of gramicidin C is associated with an increase in the permeability of the cytoplasmic membrane of the microbial cell, which disrupts its stability and causes death. Gramicidin C has an antibacterial (bactericidal) effect against a wide range of gram-positive and gram-negative microorganisms.

Cetylpyridinium chloride is an antiseptic that inhibits the growth and reproduction of pathogens that cause infectious diseases in the oral cavity. The drug has an antimicrobial effect, reduces inflammation, softens discomfort in the throat, facilitates swallowing, and when absorbed causes hypersalivation, which contributes to the mechanical cleansing of the oral cavity and pharynx from microorganisms.

Storage conditions

In a place protected from light, at a temperature not exceeding 25 °C.

Shelf life

2 years. Do not use after expiration date.

Manufacturer

Valenta Pharm JSC, Russia